[1]汪六林,巴元明△,李 刚,等.中医药防治新型冠状病毒肺炎研究*[J].西部中医药,2020,33(S1):44.
 WANG Liulin,BA Yuanming,LI Gan,et al.The Study on TCM in the Prevention and Treatment of COVID - 19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):44.
点击复制

中医药防治新型冠状病毒肺炎研究*()
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
33
期数:
2020年S1
页码:
44
栏目:
出版日期:
2021-06-30

文章信息/Info

Title:
The Study on TCM in the Prevention and Treatment of COVID - 19
作者:
汪六林1巴元明123△李 刚23李成银23李伟男23
1 湖北中医药大学,湖北 武汉 430061; 2 湖北省中医院; 3 湖北省中医药研究院
Author(s):
WANG Liulin1 BA Yuanming1 2 3 LI Gan2 3 LI Chengyin2 3 LI Weinan2 3
1 Hubei University of Chinese Medicine, Wuhan 430061, China ; 2 Hubei Provincial Hospital of TCM; 3 Hubei Provincial Academy of TCM
关键词:
新型冠状病毒肺炎流行病学中医理论中西医结合临床疗效
Keywords:
COVID - 19 the epidemiology TCM theory integrative medicine clinical effects
分类号:
R521.99
文献标志码:
A
摘要:
从“治未病”思想在新型冠状病毒肺炎(简称“新冠肺炎”)防控中的体现、中医理论在新冠肺炎防控中的优势及中医药治疗新冠肺炎临床有效3方面入手探讨新冠肺炎的中医药防治,指出中医药在急性传染病如鼠疫、天花、霍乱、疟疾、麻疹、痢疾、猩红热及SARS等的治疗中积累了丰富经验,辨证论治是起效的关键;早期介入直接关乎最终疗效;望闻问切是基本方法。在新冠肺炎的治疗中充分发挥中医药优势,探索中西医结合防治方法,传承经典,守正创新,以促进中医药在我国公共卫生应急体系中发挥更大作用。
Abstract:
TCM prevention and treatment of COVID - 19 are illustrated from the embodiment of "preventive treatment of disease" idea in the prevention and treatment of COVID - 19, the advantages of TCM theory in the prevention and treatment of COVID - 19 and clinical effects of TCM in the treatment of COVID - 19. It is pointed out that TCM has accumulated the rich experience in treating acute infectious diseases including plague, smallpox, cholera, malaria, measles, dysentery, scarflet fever, SARS and others, syndrome differentiation and treatment is the key of TCM working; early intervention is directly related to the ultimate outcome; observation, listening, questioning and pulse - taking are the basic methods. We should develop TCM advantages in the treatment of COVID - 19, explore the preventive method of integrative medicine and promote the bigger role of TCM in China’s public health emergency system by inheriting the classics, adhering to the path and innovating.

参考文献/References:

[1] 边原,王玥媛,杨勇,等.新型冠状病毒感染性肺炎抗病毒药物合理使用与药学监护[J/OL].医药导报,2020:1-19(2020-02-03)[2020-03-05].http://kns.cnki.net/kcms/detail/42.1293.R.20200203.1003.002.html.
[2] 唐志岚,牛志军,朱鹏展.新型冠状病毒肺炎与埃博拉病毒病流行病学特征及防控措施[J/OL].西部中医药,2020:1-6(2020-03-21)[2020-03-25].http://subject.med.wanfangdata.com.cn/UpLoad/Files/202003/80e9d56551c44a83a9168388bc5f8fcb.pdf.
[3] 潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J/OL].西部中医药,2020:1-4(2020-02-21)[2020-02-21].http://subject.med.wanfangdata.com.cn/UpLoad/Files/202002/17b43aa1350c4720821187f15935dffa.pdf.
[4] 曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用[J/OL].西部中医药,2020:1-3(2020-03-10)[2020-03-12].http://subject.med.wanfangdata.com.cn/UpLoad/Files/202003/2500fc875275493cbc93f668c267f516.pdf.
[5] 桑天庆,周红光.中医药在新型冠状病毒肺炎疫情中的应用[J/OL].西部中医药,2020:1-3(2020-03-10)[2020-03-12].http://subject.med.wanfangdata.com.cn/UpLoad/Files/202003/09a2a1e25dd74da195925002ce98d661.pdf.
[6] 李灿东,雷黄伟.构建全方位全周期的中医健康服务体系[J].中华中医药杂志,2019,34(4):1552-1555.
[7] 王玉光,齐文升,马家驹,等.新型冠状病毒(2019-nCoV)肺炎中医临床特征与辨证治疗初探[J].中医杂志,2020,61(4):281-285.
[8] 林举择,兰小和,王昌俊.基于卫气营血辨证和脏腑辨证相结合治疗新型冠状病毒肺炎验案1则[J].天津中医药,2020,37(3):251-254.
[9] 陈瑞,罗亚萍,徐勋华,等.基于武汉地区52例新型冠状病毒肺炎的中医证治初探及典型病案分析[J/OL].中医杂志,2020:1-4(2020-02-21)[2020-03-05].http://kns.cnki.net/kcms/detail/11.2166.R.20200220.1443.002.html.
[10] 夏文广,安长青,郑婵娟,等.中西医结合治疗新型冠状病毒肺炎34例临床研究[J].中医杂志,2020,61(5):375-382.
[11] 吕睿冰,王文菊,李欣.中药连花清瘟治疗新型冠状病毒肺炎疑似病例63例临床观察[J/OL].中医杂志,2020:1-5(2020-02-17)[2020-03-26].http://kns.cnki.net/kcms/
detail/11.2166.R.20200215.1633.004.html.
[12] 李承羽,张晓雨,刘斯,商洪才.血必净注射液治疗新型冠状病毒感染的肺炎(COVID-19)证据基础及研究前瞻[J/OL].世界科学技术-中医药现代化,2020:1-6(2020-02-19)[2020-03-25].http://kns.cnki.net/kcms/detail/11.5699.R.20200217.1242.002.html.
[13] 宋乃光,赵岩松,汤百鸣.中医药治疗急性传染病研究[J].中国医药学报,2004,19(7):389-391.

相似文献/References:

[1]王正成.嘉峪关市胆石病流行病学调查及相关因素分析[J].西部中医药,2013,26(03):67.
 WANG Zhengcheng.Epidemiological Study of Cholelithiasis and Analysis of the Related Factors in Jiayuguan Municipality[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):67.
[2]姚兴璋,李兴勇△.从流行病学浅析膝关节骨性关节炎的危险因素[J].西部中医药,2012,25(09):132.
 YAO Xing-zhang,LI Xing-yong.Analysis of Epidemiology on Risk Factors of Knee Osteoarthritis[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):132.
[3]李盛华,张绍文,樊成虎.1 005例胸腰椎骨折住院患者流行病学特征分析[J].西部中医药,2014,27(05):70.
 LI Shenghua,ZHANG Shaowen,FAN Chenghu.Analysis on Epidemiological Features of 1 005 Inpatients with Thoracolumbar Fracture[J].Western Journal of Traditional Chinese Medicine,2014,27(S1):70.
[4]唐伟,陈久红,薛金洲,等.六安市城区居民中医体质流行病学调查[J].西部中医药,2014,27(11):82.
[5]陈志龙,徐霞,赵萍,等.兰州市先天性儿童手部畸形的患病率调查[J].西部中医药,2017,30(01):57.
 CHEN Zhilong,XU Xia,ZHAO Ping,et al.Investigation on Prevalence of Congenital Children′s Clubhand in Lanzhou City[J].Western Journal of Traditional Chinese Medicine,2017,30(S1):57.
[6]刘祥敏,张先庚△,薛秒.PTSD睡眠障碍流行病学及中医调护研究进展[J].西部中医药,2018,31(09):146.
 LIU Xiangmin,ZHANG Xiangeng,XUE Miao.Research Progress on TCM Nursing and Epidemiology of Sleep Disorder of PTSD Patients[J].Western Journal of Traditional Chinese Medicine,2018,31(S1):146.
[7]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
 LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):1.
[8]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
 SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):3.
[9]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
 DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):5.
[10]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
 PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):7.

备注/Memo

备注/Memo:
*基金项目:湖北省科技厅新冠肺炎应急科技攻关项目(第一批)(2020FCA007)。 收稿日期:2020-03-05 *基金项目:湖北省科技厅新冠肺炎应急科技攻关项目(第一批)(2020FCA007)。 作者简介:汪六林(1988—),女,在读博士研究生,医师。研究方向:慢性肾脏病的中医药防治。 △通讯作者:巴元明(1961—),男,博士研究生导师,主任医师,教授。
更新日期/Last Update: 2020-04-01